Navigation Links
Dr. Geoffrey S. Ginsburg Joins Alere Board

WALTHAM, Mass., July 23, 2015 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, announced today the election of Geoffrey S. Ginsburg, M.D., Ph.D. to the Company's Board of Directors, effective immediately. Dr. Ginsburg is a founding director of the Center for Applied Genomics & Precision Medicine and also a professor of Medicine, Pathology and Biomedical Engineering, both at Duke University.

"We are thrilled that Geoff Ginsburg has joined the Alere Board of Directors," said Gregg J. Powers, Chairman of the Board of Alere. "With work spanning oncology, infectious disease, cardiovascular disease and metabolic disorders and research addressing the challenges of translating genomic information into medicine and integrating precision medicine into health, Geoff brings to our Board a wealth of expertise in applied science and experience in genomics, molecular diagnostics and personalized medicine. We look forward to his contributions in guiding the future direction of Alere."

"I am delighted to join the Alere Board of Directors and to help the Company fulfill its vision of bringing high-performance, rapid diagnostics to the point of care globally," said Geoffrey S. Ginsburg, Professor of Medicine, Pathology and Biomedical Engineering at Duke University. "I congratulate the Company on its recent progress and business transformation."

In addition to his current positions at Duke University, Dr. Ginsburg also serves as an expert panel member for Genome Canada, as a member of the Board of External Experts for the National Heart, Lung and Blood Institute, as Co-Chair of the Institute of Medicine's Roundtable on Genome-Based Research to Human Health, as a member of the advisory council for the National Center for Accelerating Translational Science, as co-Chair of the Cures Acceleration Network, co-chair of the Global Genomic Medicine Collaborative, and as a member of the World Economics Forum's Global Agenda Council on the Future of the Health Sector. Dr. Ginsburg worked at Millennium Pharmaceuticals, Inc. from 1997 to 2004, serving as senior program director for cardiovascular diseases and later as Vice President of Molecular and Personalized Medicine, where he was responsible for developing pharmacogenomics and biomarker strategies for therapeutics.

About Alere
Alere believes that when diagnosing and monitoring health conditions, Knowing now matters™. Alere delivers on this vision by delivering reliable and actionable information through rapid diagnostic tests, enhancing clinical and economic health outcomes globally. Headquartered in Waltham, Mass., Alere focuses on rapid diagnostics for infectious disease, cardiometabolic disease and toxicology. For more information on Alere, please visit

SOURCE Alere Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Lakewood-Amedex Inc. Appoints Geoffrey F. Cox To Its Board Of Directors
2. Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures
3. Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers
4. Specialty Operations Solutions joins The WorkingBuildings Companies
5. Dr. M. Fatih Yanik joins Intellimedix
6. Romanoff Joins Innovative Statewide Program to Combat Abuse of Prescription Pain Medications
7. Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign
8. Tom Dugan Joins SurgiQuest, Inc. as President and Chief Commercialization Officer
9. Dr. Richard Popiel Joins Care Team Connects Board of Directors
10. Jay Shreiner Joins NxStage Board of Directors
11. Froedtert & The Medical College of Wisconsin Clinical Cancer Center Joins Elekta and Philips Research Consortium on MRI-Guided Radiation Therapy
Post Your Comments:
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
(Date:9/13/2017)... OrthoAtlanta has been named the official orthopedic and sports ... the 2018 College Football Playoff (CFP) National Championship to be ... Atlanta, Georgia . OrthoAtlanta is proud to ... in many activities leading up to, and including the national ... OrthoAtlanta ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a missionary ... Journey: From the Mountains to the Mission Field” is the creation of published author, ... ages and currently teaches a class of ladies at her church, which she has ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... Leading pediatric ... peers in Washington, D.C., for the 49th Congress of the International Society of ... Vice President of the Center for Cancer and Blood Disorders at Children’s ...
Breaking Medicine News(10 mins):